期刊文献+

血小板反应素-4基因A387P多态性与心肌梗死的相关性研究

Correlation of thrombospondin-4 A387P polymorphism with myocardial infarction
下载PDF
导出
摘要 目的 研究中国华东地区汉族人群血小板反应素-4(thrombospondin-4,TSP-4)基因G29926C(A387P)多态性与心肌梗死(MI)发病的关联性.方法 应用聚合酶链反应一限制性片段长度多态性方法分析TSP-4 A387P多态性,将639例患者分为MI组和对照组,MI组为302例经冠状动脉造影确诊的MI患者,对照组为337例冠状动脉造影阴性、排除冠心病诊断者.结果 GC基因型在两组的分布,差异无显著性意义(5.3%νs7.1%,P=0.34),未检测到CC纯合予.C等位基因频率在两组的分布,差异无显著性意义(2.6%νs 3.6%,P=0.35),对照组TSP-4 387A→P变异频数明显低.多元logistic回归分析显示TSP-4 A387P多态性与MI的发生无显著性相关(OR=0.81,95%CI:0.41~1.62,P=0.55).结论 TSP-4基因387A→P变异在中国华东地区汉族人群中发生频率明显低,且与MI的发病无显著相关性. Objective To investigate the possible association between the thrombospondin-4 (TSP-4) gene G29926C (A387P) polymorphism and myocardial infarction (MI) in the Chinese Han population. Methods A case-control study was conducted in 302 patients with angiographically documented MI and 337 control subjects free from coronary artery disease and had normal coronary angiograms. The TSP-4 A387P polymorphism was determined by polymerase chain reaction and restriction fragment length polymorphism analysis. Results The frequencies of GC genotype were 5.3% and 7.1% in MI group and control group ( P=0.34). No homozygote of the C allele was detected. The prevalence of the C allele was not significantly different between patients with MI and controls (2.6% vs 3.6%, P =0.35). The prevalence of the C allele in control subjects was lower. Multivariate logistic regression analysis indicated that there was no significant correlation between TSP-4 A387P polymorphism and MI ( OR=0.81, 95% CI=0. 41-1.62, P=0.55). Conclusion The TSP-4 A387P variation shows a dramatically lower prevalence in the Chinese Han population and has no significant correlation with risk of MI.
出处 《中华老年心脑血管病杂志》 CAS 北大核心 2007年第6期376-378,共3页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
关键词 心肌梗塞 凝血酶敏感蛋白类 多态性 限制性片段长度 聚合酶链反应 myocardial infarction thrombospondins polymorphism, retriction fragment length polymerase chain reaction
  • 相关文献

参考文献8

  • 1Adams JC, Lawler J. The thrombospondins[J]. Int J Biochem Cell Biol, 2004, 36: 961-968.
  • 2Stenina OI, Byzova TV, Adams JC, et al. Coronary artery disease and the thrombospondin single nucleotide polymorphisms[J]. Int J Biochem Cell Biol, 2004, 36: 1013-1030.
  • 3Topol EJ, McCarthy J, Gabriel S, et al. Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarction[J].Circulation, 2001, 104:2641-2644.
  • 4Boekholdt SM, Trip MD, Peters RJ, et al. Thrombospondin-2 polymorphism is associated with a reduced risk of premature myocardial infarction [J]. Arterioscler Thromb Vase Biol,2002, 22: e24-e27.
  • 5Yamada Y, Izawa H, Ichihara S, et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes[J]. N Engl J Med, 2002, 347:1916-1923.
  • 6Zhou XY, Huang JF, Chen JH, et al. Thrombospopdin-4 A387P polymorphism is not associated with coropary artery disease and myocardial infarction in the Chinese Han population[J]. Clin Sci, 2004, 106: 495-500.
  • 7McCarthy JJ, Parker A, Salem R, et al. Large scale association analysis for identification of genes underlying premature coronary heart disease: cumulative perspective from analysis of 111 candidate genes[J]. J Med Genet, 2004, 41: 334-341.
  • 8Wessel J, Topol EJ, Ji M. et al. Replication of the association between the thrombospondin-4 A387P polymorphism and myocardialinfarction [J]. Am Heart J, 2004, 147: 905-909.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部